Thursday Nov 06, 2025
Ep. 17: Transforming MDI with InPen
Multiple daily injections (MDI) doesn't have to stay stuck in the past. Discover how the InPen™ system is transforming multiple daily injections - bringing smart, connected support to simplify MDI.
Product usage represented may not be approved or cleared in all markets.
The InPen system, consisting of a mobile app and home-use reusable pen injector, requires a prescription. It is for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin.
The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPen system dose calculator, a component of the InPen system app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data.
For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use.
For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use.
For additional product and important safety considerations, see User Guide and https://bit.ly/InPenSafety
Connectivity, proper settings and user interaction required, including manual logging of rapid-acting insulin given by other means. WARNING: not doing so may lead to hypoglycemia, which could result in serious injury or death.